Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 759483, 9 pages
http://dx.doi.org/10.1155/2013/759483
Research Article

Salvianolic Acid B Prevents Arsenic Trioxide-Induced Cardiotoxicity In Vivo and Enhances Its Anticancer Activity In Vitro

1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China
2Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
3School of Biological Sciences, University of Edinburgh, King’s Buildings, Edinburgh EH9 3JU, UK
4Academy of Chinese Materia Medica, Wenzhou Medical College, Wenzhou 325035, China

Received 22 December 2012; Revised 2 March 2013; Accepted 2 March 2013

Academic Editor: Angelo Antonio Izzo

Copyright © 2013 Min Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Zhu, Z. Chen, V. Lallemand-Breitenbach, and H. de Thé, “How acute promyclocytic leukaemia revived arsenic,” Nature Reviews Cancer, vol. 2, no. 9, pp. 705–713, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Lengfelder, W. K. Hofmann, and D. Nowak, “Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia,” Leukemia, vol. 26, no. 3, pp. 433–442, 2012. View at Google Scholar
  3. K. Ohnishi, H. Yoshida, K. Shigeno et al., “Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia,” Annals of Internal Medicine, vol. 133, no. 11, pp. 881–885, 2000. View at Google Scholar · View at Scopus
  4. D. Unnikrishnan, J. P. Dutcher, N. Varshneya et al., “Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide,” Blood, vol. 97, no. 5, pp. 1514–1516, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Naito, M. Kobayashi, N. Sahara et al., “Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy,” International Journal of Hematology, vol. 83, no. 4, pp. 318–323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. I. Chang, B. Jin, P. Youn, C. Park, J. D. Park, and D. Y. Ryu, “Arsenic-induced toxicity and the protective role of ascorbic acid in mouse testis,” Toxicology and Applied Pharmacology, vol. 218, no. 2, pp. 196–203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Y. Zhao, G. Y. Li, Y. Liu et al., “Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo,” The British Journal of Pharmacology, vol. 154, no. 1, pp. 105–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. K. Das, R. Sahu, T. K. Dua et al., “Arsenic-induced myocardial injury: protective role of Corchorus olitorius leaves,” Food and Chemical Toxicology, vol. 48, no. 5, pp. 1210–1217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Manna, M. Sinha, and P. C. Sil, “Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid,” Archives of Toxicology, vol. 82, no. 3, pp. 137–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Chen, F. Wang, F. S. C. Lee, X. Wang, and M. Xie, “Separation and identification of water-soluble salvianolic acids from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography and ESI-MS analysis,” Talanta, vol. 69, no. 1, pp. 172–179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Zhou, M. Chow, and Z. Zuo, “Improved quality control method for Danshen products-Consideration of both hydrophilic and lipophilic active components,” Journal of Pharmaceutical and Biomedical Analysis, vol. 41, no. 3, pp. 744–750, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. G. R. Zhao, H. M. Zhang, T. X. Ye et al., “Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B,” Food and Chemical Toxicology, vol. 46, no. 1, pp. 73–81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Xu, Y. Deng, L. Feng et al., “Cardio-protection of salvianolic acid B through inhibition of apoptosis network,” PLoS One, vol. 6, no. 9, article e24036, 2011. View at Google Scholar
  14. Q. L. Wang, Y. Y. Tao, J. L. Yuan, L. Shen, and C. H. Liu, “Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-β1 signal transduction pathway in vivo and in vitro,” BMC Cell Biology, vol. 11, article 31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Wang, G. B. Sun, X. Sun et al., “Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway,” Toxicology Letters, vol. 216, no. 2-3, pp. 100–107, 2013. View at Google Scholar
  16. M. Rajadurai and P. S. M. Prince, “Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats,” Toxicology, vol. 230, no. 2-3, pp. 178–188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Nakahara, K. Nakamura, N. Yamanaka et al., “Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear Factor-κB activation in human gastric carcinoma cells,” Clinical Cancer Research, vol. 9, no. 14, pp. 5409–5416, 2003. View at Google Scholar · View at Scopus
  18. W. C. Chou and C. V. Dang, “Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies,” Current Opinion in Hematology, vol. 12, no. 1, pp. 1–6, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Kumazaki, H. Ando, A. Sasaki et al., “Protective effect of α-lipoic acid against arsenic trioxide-induced acute cardiac toxicity in rats,” Journal of Pharmacological Sciences, vol. 115, no. 2, pp. 244–248, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Y. Saad, K. M. Alkharfy, and M. M. Arafah, “Cardiotoxic effects of arsenic trioxide/imatinib mesilate combination in rats,” Journal of Pharmacy and Pharmacology, vol. 58, no. 4, pp. 567–573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Hao, T. Xie, A. Korotcov et al., “Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways,” International Journal of Cancer, vol. 124, no. 9, pp. 2200–2209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Guo, C. K. Lei, and M. Shan, “Study of growth inhibitory effect and apoptosis induced by different matches of Tanshinone IIA and Salvianolic Acid B on Acute Promyelocytic Leukemia cells (HL-60),” Journal of Chinese Medicinal Materials, vol. 31, no. 10, pp. 1512–1514, 2008. View at Google Scholar · View at Scopus
  23. Q. L. Wang, Q. Wu, Y. Y. Tao, C. H. Liu, and H. El-Nezami, “Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells,” Hepatobiliary and Pancreatic Diseases International, vol. 10, no. 5, pp. 502–508, 2011. View at Google Scholar
  24. X. Li and Z. Darzynkiewicz, “Cleavage of poly(ADP-ribose) polymerase measured in situ in individual cells: relationship to DNA fragmentation and cell cycle position during apoptosis,” Experimental Cell Research, vol. 255, no. 1, pp. 125–132, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. S. H. Kaufmann, S. Desnoyers, Y. Ottaviano, N. E. Davidson, and G. G. Poirier, “Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis,” Cancer Research, vol. 53, no. 17, pp. 3976–3985, 1993. View at Google Scholar · View at Scopus
  26. Y. Xu, Z. Liu, J. Sun et al., “Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo,” PLoS One, vol. 6, no. 12, article e28335, 2011. View at Google Scholar
  27. Z. Yuan, F. Wang, Z. Zhao et al., “Bim-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells,” PLoS ONE, vol. 6, no. 5, Article ID e20586, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. P. M. Kang, P. Yue, and S. Izumo, “New insights into the role of apoptosis in cardiovascular disease,” Circulation Journal, vol. 66, no. 1, pp. 1–9, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Liu, B. Chen, Y. Lu, Y. Guan, and F. Chen, “JNK-dependent Stat3 phosphorylation contributes to Akt activation in response to arsenic exposure,” Toxicological Sciences, vol. 129, no. 2, pp. 363–371, 2012. View at Google Scholar